[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355190-105":59,"doc-detail-355190-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","polygenic-risk-and-germline-genetics-for-prostate-cancer-in-asians-where-do-we-stand","Polygenic risk and germline genetics for prostate cancer in Asians - Where do we stand?","","Prostate cancer shows marked ethnic differences in genetic architecture, limiting the transferability of European polygenic risk scores (PRS) and germline testing to Asian populations. This review synthesizes evidence from 2020–2025 on PRS and germline genetics in Asian cohorts, covering Chinese, Japanese, and Korean studies. Population-specific PRS stratify risk with 4–5-fold increases in the top decile, while germline profiling reports deleterious variants in 25.1–29% of Chinese patients, and the 2022 Hong Kong Consensus tailors germline guidance for Asians. Key gaps remain, including reliance on incidence prediction and limited prospective validation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/polygenic-risk-and-germline-genetics-for-prostate-cancer-in-asians-where-do-we-stand/355190/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/polygenic-risk-and-germline-genetics-for-prostate-cancer-in-asians-where-do-we-stand/355190.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are European-derived polygenic risk scores limited for Asian prostate cancer patients?","Question",{"text":113,"@type":114},"Because genetic architecture and allele frequencies differ between populations, European PRS accuracy decreases in Asians. This review emphasizes the need for population-specific validation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What do studies report about polygenic risk score stratification in Asian men?",{"text":118,"@type":114},"Recent studies show that population-specific PRS models can stratify risk, with individuals in the highest decile experiencing about a 4-to 5-fold increased risk.",{"name":120,"@type":111,"acceptedAnswer":121},"What proportions of Chinese patients carry deleterious germline variants, and which gene is most frequently involved?",{"text":122,"@type":114},"Germline profiling indicates about 25.1%–29% of Chinese patients harbor deleterious variants, most frequently involving BRCA2.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355190,1790378548,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Review Article  \nInvestig Clin Urol 2026;67:113-122. [https://doi.org/10.4111/icu.20250694](https://doi.org/10.4111/icu.20250694)[ ](https://doi.org/10.4111/icu.20250694)[pISSN 2466-0493](pISSN 2466-0493) • eISSN 2466-054X  \nPolygenic risk and germline genetics for prostate cancer in Asians: Where do we stand?  \nSang Hun Song1,2, Sung Kyu Hong1,2  \n1Department of Urology, Seoul National University Bundang Hospital, Seongnam, 2Department of Urology, Seoul National University College of Medicine, Seoul, Korea  \nProstate cancer exhibits marked ethnic differences in genetic architecture. Although polygenic risk scores (PRS) and germline genetic testing have shown clinical utility in European populations, their applicability to Asian populations remains limited. This review synthesizes evidence published between 2020 and 2025 on PRS and germline genetics in Asian prostate cancer cohorts, focusing on Chinese, Japanese, and Korean populations. Recent studies demonstrate that population-specific PRS models effectively stratify prostate cancer risk in Asian men, with individuals in the highest decile showing a 4-to 5-fold increased risk. The 2025 BARCODE1 trial reported a 40.0% cancer detection rate, with 55.1% clinically significant disease, among PRS-selected European men, highlighting the need for population-specific validation in Asians. Germline profiling indicates that 25.1%–29% of Chinese patients harbor deleterious variants, most frequently involving BRCA2 . Ethnic-specific susceptibility variants have also been identified, including HOXB13 G132E in Asians, contrasting with the G84E variant predominant in Europeans. The 2022 Hong Kong Consensus provides the first comprehensive guideline tailored to germline testing in Asian populations. Despite these advances, current PRS models primarily predict disease incidence rather than aggressive phenotypes. Key challenges include smaller genome-wide association study sample sizes, limited prospective validation, and heterogeneous clinical and research infrastructure across Asia. In conclusion, while substantial progress has been made in characterizing genetic risk in Asian prostate cancer, European-derived models show reduced accuracy. Future priorities include large-scale multiethnic collaborations, prospective validation studies, and development of predictors for aggressive disease.  \nKeywords: Genetics; Germline mutation; Polygenic inheritance; Polygenic risk score; Prostate cancer  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0](http://creativecommons.org/licenses/by-nc/4.0)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nINTRODUCTION  \nProstate cancer ranks as the second most common male cancer globally, with rising incidence in Asian countries over recent decades. In Taiwan, cases doubled from 2000 to 2017, with similar trends across China, Japan, and South Korea [1-3]. In Japan specifically, age-standardized incidence rose from approximately 15 per 100,000 in 2000 to 45.6 per 100,000 in 2018—a threefold increase over two decades—though  \nstill lower than Western countries [4]. These epidemiological shifts reflect complex interactions between environmental changes, improved detection, and underlying genetic susceptibilities that manifest differently across ethnicities.  \nGenetic factors account for approximately 42% of prostate cancer risk, making it among the most heritable cancers [5]. Two complementary genetic approaches have emerged: polygenic risk scores (PRS) aggregating common variants from genome-wide association studies, and germline testing  \nReceived: December 14, 2025 • Revised: December 30, 2025 • Accepted: January 12, 2026 • Published online: February 26, 2026  \nCorresponding Author: Sung Kyu Hong  [https://orcid.org/0000-0002-8344-6774](https://orcid.org/0","cbCaie0ddc0xObfL","https://ap.wps.com/l/cbCaie0ddc0xObfL","pdf",410186,"English","# Introduction\n## Epidemiology and genetic contribution\n## Two complementary genetic approaches: PRS and germline testing\n# Core evidence and clinical implications\n## PRS performance in Asian cohorts\n## Germline profiling and ethnic-specific variants\n## Consensus guidance for germline testing in Asians\n# Challenges and future directions\n## Limitations of current PRS models\n## Need for validation, larger samples, and aggressive phenotype predictors","[{\"question\":\"Why are European-derived polygenic risk scores limited for Asian prostate cancer patients?\",\"answer\":\"Because genetic architecture and allele frequencies differ between populations, European PRS accuracy decreases in Asians. This review emphasizes the need for population-specific validation.\"},{\"question\":\"What do studies report about polygenic risk score stratification in Asian men?\",\"answer\":\"Recent studies show that population-specific PRS models can stratify risk, with individuals in the highest decile experiencing about a 4-to 5-fold increased risk.\"},{\"question\":\"What proportions of Chinese patients carry deleterious germline variants, and which gene is most frequently involved?\",\"answer\":\"Germline profiling indicates about 25.1%–29% of Chinese patients harbor deleterious variants, most frequently involving BRCA2.\"}]","Polygenic risk and germline genetics for prostate cancer in Asians - Where do we stand? | PDF",1790116620,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e7abb0544e97ecc0f2d9a2279010349.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/069de2bb2c27e825a4ac8dad968c6090.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/407420108e2272f3d4138eb95006b0cc.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8ca139a2b0d93460daa79af5acead34.webp",980,1306]